Medical News

RSS

Lund researchers create nerve cells from human skin

A research breakthrough has proven that it is possible to reprogram mature cells from human skin directly into brain cells, without passing through the stem cell stage. The unexpectedly simple technique involves activating three genes in the skin cells; genes which are already known to be active in the formation of brain cells at the foetal stage.

9 Jun 2011

ASI announces successful completion of $10 million round of financing

Access Scientific, Inc. (ASI) today announced the successful completion of a $10 million round of financing. The round was led by CAC and further supported by the company's previous institutional investors.

9 Jun 2011

ImmunoCellular expands ICT-107 Phase II clinical trial for glioblastoma multiforme

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced the expansion of sites for its Phase II clinical trial of ICT-107. ICT-107 is the Company's dendritic cell based cancer vaccine candidate targeting multiple tumor antigens for the treatment of glioblastoma multiforme (GBM).

9 Jun 2011

Birner Dental Management increases quarterly dividend to $.22 per share

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices and Vantage Dental Implant Center, announced its regular quarterly dividend. The Company's board of directors has declared a quarterly cash dividend of 22 cents per share of common stock.

9 Jun 2011

Synaptophysin controls replacement of vesicles

A University of Wisconsin-Madison research team has solved a 25-year mystery that may lead to better treatments for people with learning deficits and mental retardation.

9 Jun 2011

Tips for preventing outdoor home-related injury: AANS

The nail-gun neck injury and treatment incurred by a 25-year-old carpenter described in the Journal of Neurosurgery: Spine article might read like an oddity, but nail guns are actually a common form of penetrating low-velocity injury. What made this case unique was that the patient incurred a penetrating wound to the cervical spine by a barbed nail lodged in close proximity to the right vertebral artery.

9 Jun 2011

First Edition: June 9, 2011

Today's headlines include reports from yesterday's action in an Atlanta courtroom where oral arguments were held in an appeal related to the multi-state challenge to the health law.

9 Jun 2011

Claims and counterclaims over BPA health risks

Despite years of scientific studies, reports, lawsuits, congressional inquiries, claims and counterclaims, the question of whether bisphenol A (BPA) poses health threats to people lacks a definitive answer, according to a package of articles on the controversial substance in the current edition of Chemical & Engineering News (C&EN), ACS's weekly newsmagazine.

9 Jun 2011

CLC Bio unveils new framework for visualizing, combining and analyzing genome data

Today at the Copenhagenomics conference, CLC bio has revealed Genomics Gateway - a new framework for visualizing, combining and analyzing genome data.

9 Jun 2011

Ilex, Cerus partner to distribute INTERCEPT Blood System in Israel and South Africa

Cerus Corporation today announced today that it has entered into agreements with Ilex Biotech Limited to distribute Cerus' INTERCEPT Blood System for platelets and plasma in South Africa and Israel.

9 Jun 2011

Celerion earns ANVISA certification to conduct clinical research operations in Belfast, Lincoln

Celerion, the premier provider of innovative early stage drug development solutions, is pleased to announce that its clinical research operations in Belfast, Northern Ireland UK, and its clinical research and bioanalytical services operations in Lincoln, Nebraska USA, have been certified by the Brazilian National Health Surveillance Agency.

9 Jun 2011

Vertex announces interim results from VX-770 and VX-809 Phase 2 study on cystic fibrosis

Vertex Pharmaceuticals Incorporated today announced interim results from the first part of a Phase 2 study designed to evaluate multiple combination regimens of VX-770 and VX-809, Vertex's lead medicines in development that aim to treat the defective protein that causes cystic fibrosis.

9 Jun 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen Corporation today reported results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

9 Jun 2011

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck, known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the highest dose of simvastatin, 80 mg, and the use of simvastatin with certain other medicines.

9 Jun 2011

Foundation for Peripheral Neuropathy to launch first ever national PN research registry

What starts as burning, numbness, pain, and/or tingling in the feet, or hands in some can turn into a debilitating condition. Peripheral Neuropathy (PN), one of the largest and most common neurodegenerative disorders, affects more than 20 million Americans of all races and ethnic backgrounds.

9 Jun 2011

Make antiretroviral therapy 'cornerstone' of HIV prevention

Ahead of the U.N. High Level Meeting on AIDS, AVAC: Global Advocacy for HIV Prevention and multiple signatories in a statement call on governments, advocates and researchers to act on the evidence from HPTN 052 and make antiretroviral therapy a cornerstone of the set of proven strategies we have to prevent and treat HIV.

9 Jun 2011

Leadership Reads Initiative to minimize teen alcohol consumption and drug use

The incidence of alcohol poisoning, alcohol-related violence, and alcohol-impaired driving is increasing at an alarming rate among teens. If teens start to drink early, they are six times more likely to develop alcohol dependence.

9 Jun 2011

GeneTex to introduce new Easy-iPSC minicircle DNA vector technology in June

GeneTex, a leading manufacturer of antibodies for research use, is pleased to announce they will be launching several new exciting products in June, including the new Easy-iPSC minicircle DNA vector technology.

9 Jun 2011

IAS calls on leaders to include HIV cure research in global strategy

The International AIDS Society (IAS) in a statement released ahead of the U.N. High Level Meeting on AIDS "calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies."

9 Jun 2011

JDRF, Selecta Biosciences partner to develop type 1 diabetes vaccine

The Juvenile Diabetes Research Foundation (JDRF) and Selecta Biosciences, Inc. announced today that they have established a research collaboration to support Selecta's development of a vaccine technology, which may subsequently help to better treat and potentially prevent type 1 diabetes.

9 Jun 2011

Medical News

Lund researchers create nerve cells from human skin

ASI announces successful completion of $10 million round of financing

ImmunoCellular expands ICT-107 Phase II clinical trial for glioblastoma multiforme

Birner Dental Management increases quarterly dividend to $.22 per share

Synaptophysin controls replacement of vesicles

Tips for preventing outdoor home-related injury: AANS

First Edition: June 9, 2011

Claims and counterclaims over BPA health risks

CLC Bio unveils new framework for visualizing, combining and analyzing genome data

Ilex, Cerus partner to distribute INTERCEPT Blood System in Israel and South Africa

Celerion earns ANVISA certification to conduct clinical research operations in Belfast, Lincoln

Vertex announces interim results from VX-770 and VX-809 Phase 2 study on cystic fibrosis

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Foundation for Peripheral Neuropathy to launch first ever national PN research registry

Make antiretroviral therapy 'cornerstone' of HIV prevention

Leadership Reads Initiative to minimize teen alcohol consumption and drug use

GeneTex to introduce new Easy-iPSC minicircle DNA vector technology in June

IAS calls on leaders to include HIV cure research in global strategy

JDRF, Selecta Biosciences partner to develop type 1 diabetes vaccine

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News